Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 40
CT radiomics help stratify risk in NSCLC patients
By
Erik L. Ridley
Tuesday, November 30 | 3:00 p.m.-4:00 p.m. | SSIN05-1 | Room S401In this session, researchers will share how CT radiomics can enable prognostic stratification in patients with non-small cell lung cancer (NSCLC).
November 21, 2021
Clinical decision-support software gets a helping hand from AI
By
Erik L. Ridley
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSIN01-2 | Room E350In this talk, researchers will share positive results from providing clinicians with artificial intelligence (AI)-assisted clinical indications when ordering imaging studies using clinical decision-support software.
November 21, 2021
Radiomics helps predict rectal cancer treatment response
By
Erik L. Ridley
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSGI01-1 | Room S404The combination of radiologist assessment and a radiomics classifier can significantly improve the accuracy of MRI for predicting treatment response in cases of rectal cancer, according to this scientific presentation.
November 21, 2021
Monrol and MTTI ink Lu-177 supply deal
By
AuntMinnie.com staff writers
EczacıbaŞı-Monrol Nuclear Products has signed an agreement to supply Molecular Targeting Technologies (MTTI) with no-carrier-added lutetium-177 (Lu-177).
November 18, 2021
PSMA-PET predicts patient response to chemotherapy
By
Will Morton
PET imaging with a radiotracer based on prostate-specific membrane antigen (PSMA) can help predict whether patients with metastatic prostate cancer will respond to chemotherapy, a significant finding in efforts to tailor therapy to individual patients, according to a study published November 12 in the
Journal of Nuclear Medicine
.
November 18, 2021
NorthStar to buy accelerator for actinium-225 production
By
AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has inked a deal with Ion Beam Applications (IBA) to purchase one of IBA's Rhodotron TT300 HE electron-beam accelerators for the commercial production of actinium-225 (Ac-225) at its new production facility in Beloit, WI.
November 17, 2021
Reduced CT dose effective for imaging pediatric cancer patients
By
Kate Madden Yee
Sunday, November 28 | 2:30 p.m.-3:00 p.m. | SSPD02-2 | Room TBACincinnati Children's Hospital researchers have found that CT with a reduced radiation dose identifies with high specificity more than 90% of lung nodules in children with cancer.
November 17, 2021
MIM gets FDA nod for molecular radiotherapy software
By
AuntMinnie.com staff writers
Medical imaging software developer MIM software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SurePlan MRT molecular radiotherapy software.
November 16, 2021
Hypofractionated radiation therapy stops vaginal bleeding faster
By
Amerigo Allegretto
Wednesday, December 1 | 9:30 a.m.-10:30 a.m. | SSRO03-2 | Room TBAIn this presentation, researchers from the University of Alabama at Birmingham will look at the effects of radiotherapies on vaginal bleeding for women with gynecological tumors.
November 15, 2021
Mirion to acquire CIRS in $54M deal
By
AuntMinnie.com staff writers
Mirion Technologies recently signed an agreement to acquire Computerized Imaging Reference Systems (CIRS), a provider of imaging and radiation therapy phantoms, in a deal worth about $54Â million.
November 11, 2021
ANSTO to partner with Cyclotek on theranostics facility
By
AuntMinnie.com staff writers
The Australian Nuclear Science and Technology Organisation (ANSTO) is entering into a joint venture with Cyclotek to build a new theranostics facility in Melbourne.
November 11, 2021
Clarity hits milestone in study of radiopharmaceutical
By
AuntMinnie.com staff writers
Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer.
November 11, 2021
Previous Page
Page 40 of 464
Next Page